Literature DB >> 12713086

Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.

Sung Hee Chung1, Olof Heimbürger, Peter Stenvinkel, Tao Wang, Bengt Lindholm.   

Abstract

OBJECTIVE: To evaluate the possible associations between peritoneal transport rate (PTR), fluid removal, inflammation, and nutritional status in patients treated with peritoneal dialysis (PD) for more than 6 months, and the impact of these factors on subsequent patient survival. DESIGN AND PATIENTS: A prospective study of 82 PD patients (48 males) that had been treated with PD more than 6 months. Based on the dialysate-to-plasma creatinine ratio at 4 hours of dwell (D/P Cr; mean +/- 1 SD), the patients were classified as having a high (H), high-average (HA), low-average (LA), or low (L) PTR.
SETTING: Single PD unit in a university hospital. MAIN OUTCOME MEASURES: The PTR, evaluation of adequacy of dialysis and nutritional status, and biochemical analyses were assessed at 10.8 +/- 2.8 months after the start of PD.
RESULTS: Compared to L and LA (L/LA) transporters, H and HA (H/HA) transporters had increased dialysate protein loss, glucose absorption from dialysate, and peritoneal creatinine clearance (CCr), and decreased night ultrafiltration volume and total Kt/V urea. However, nutritional variables, 24-hour total fluid removal (TFR), total CCr, and residual renal function were not significantly different between the two groups. The 24-hour TFR correlated significantly with D/P Cr (rho = -0.25), mean arterial pressure (rho = -0.23), serum albumin (rho = 0.25), normalized protein equivalent of total nitrogen appearance (rho = 0.34), lean body mass (LBM) calculated from creatinine kinetics (rho = 0.41), total Kt/N urea (rho = 0.42), and total CCr (rho = 0.30). The group with serum C-reactive protein (sCRP) > or = 10 mg/L had a higher proportion of patients with reduced (< 1,000 mL) TFR compared to the group with sCRP < 10 mg/L (38% vs 16%, p = 0.04). Two-year patient survival rates from the time of the assessment were not different between the different transport groups (78% vs 73% for H/HA and L/LA, p = 0.99). Upon Cox proportional hazards multivariate analysis, age and high sCRP were independent predictors of mortality.
CONCLUSIONS: This study shows that, in a selected group of prevalent PD patients assessed after more than 6 months of PD therapy, (1) inflammation was an independent predictor for mortality; (2) reduced TFR was associated with impaired nutritional status, decreased small solute clearance, and inflammation; and (3) peritoneal transport status was not significantly associated with nutritional status and was not associated with subsequent patient survival. These results indicate that a high peritoneal solute transport rate, as such, should not be regarded as a relative contraindication for PD. Instead, the results suggest that more attention should be given to inflammation and inadequate fluid removal as predictors of mortality in PD patients.

Entities:  

Mesh:

Year:  2003        PMID: 12713086

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  7 in total

1.  Cardiorenal syndrome type 4: a review.

Authors:  Anna Clementi; Grazia Maria Virzì; Ching Yan Goh; Dinna N Cruz; Antonio Granata; Girogio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

2.  Novel Equations for Estimating Lean Body Mass in Peritoneal Dialysis Patients.

Authors:  Jie Dong; Yan-Jun Li; Rong Xu; Zhi-Kai Yang; Ying-Dong Zheng
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

3.  Simulating inadequate dialysis and its correction using an individualized patient-derived nomogram.

Authors:  Alison Joanne Lee; Kevin Kho; Kee-Seng Chia; Tze-Liang Oi; Christopher Yap; Pei-Pei Foong; Yew-Weng Lau; Lee-Kean Lim; Eric Aragon; Chien-Wyei Liew; Hui-Kim Yap
Journal:  Pediatr Nephrol       Date:  2009-07-16       Impact factor: 3.714

4.  A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics.

Authors:  Takeyuki Hiramatsu; Akinori Hobo; Takahiro Hayasaki; Koki Kabu; Shinji Furuta
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

5.  The peritoneal-renal syndrome.

Authors:  Sharon J Nessim; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

6.  High peritoneal transport status was not associated with mortality in peritoneal dialysis patients with diabetes.

Authors:  Naya Huang; Jiehui Chen; Li Fan; Qian Zhou; Qingdong Xu; Ricong Xu; Liping Xiong; Xueqing Yu; Haiping Mao
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  Peritoneal Protein Loss Is Not Associated With Sarcopenia in Peritoneal Dialysis Patients.

Authors:  Jun Young Do; A Young Kim; Seok Hui Kang
Journal:  Front Med (Lausanne)       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.